Rhinovirus News and Research

RSS
Rhinovira are the most common viral infective agents in humans, and a causative agent of the common cold (about 49.12159% of the cases of the common cold are caused by this virus). It is lytic in nature. There are over a 100 recognized types of rhinovira that differ based on their varying surface proteins.

Further Reading

SARS-CoV-2 infection and severity are strongly associated with nasal microbiota

SARS-CoV-2 infection and severity are strongly associated with nasal microbiota

As COVID restrictions were removed, Texas saw an increase in seasonal respiratory virus infections

As COVID restrictions were removed, Texas saw an increase in seasonal respiratory virus infections

Nanoparticle-based disinfectant could be a powerful weapon against pathogenic viruses

Nanoparticle-based disinfectant could be a powerful weapon against pathogenic viruses

How early interferon curbs SARS-CoV-2 infection

How early interferon curbs SARS-CoV-2 infection

Peptoids could one day cure or prevent herpes, COVID-19

Peptoids could one day cure or prevent herpes, COVID-19

SARS-CoV-2 detection by machine learning surface-enhanced Raman spectroscopy

SARS-CoV-2 detection by machine learning surface-enhanced Raman spectroscopy

Large nanodiscs simulate viral entry into host cells

Large nanodiscs simulate viral entry into host cells

Budesonide’s antiviral effect against SARS-CoV-2

Budesonide’s antiviral effect against SARS-CoV-2

Can a prior rhinovirus infection protect against COVID-19?

Can a prior rhinovirus infection protect against COVID-19?

How the common cold can provide protection against COVID-19

How the common cold can provide protection against COVID-19

Exposure to common cold virus can protect against COVID-19 infection

Exposure to common cold virus can protect against COVID-19 infection

Researchers review the therapeutic potential of resveratrol nasal formulations in COVID-19

Researchers review the therapeutic potential of resveratrol nasal formulations in COVID-19

New drug effectively prevents severe COVID-19 in mice infected with SARS-CoV-2

New drug effectively prevents severe COVID-19 in mice infected with SARS-CoV-2

New peptide-like molecules could treat herpes, COVID-19, and the common cold

New peptide-like molecules could treat herpes, COVID-19, and the common cold

STING agonist diABZI shows promise against SARS-CoV-2 variants

STING agonist diABZI shows promise against SARS-CoV-2 variants

COVID-19 prevention strategies may have led to a decrease in common respiratory infections

COVID-19 prevention strategies may have led to a decrease in common respiratory infections

Microbiota modulation and re-establishment of eubiosis could help curb COVID-19 complications

Microbiota modulation and re-establishment of eubiosis could help curb COVID-19 complications

Researchers develop innovative profiling methods for SARS-CoV-2 infection

Researchers develop innovative profiling methods for SARS-CoV-2 infection

What makes viruses infectious?

What makes viruses infectious?

Study finds surprising defensive functions of the immune system against new viral attacks

Study finds surprising defensive functions of the immune system against new viral attacks